FDA has cleared a2z Radiology AI's Abdo-Triage tool to triage 10 additional findings on abdomen-pelvis CT scans.
Key Details
- 1a2z Radiology AI Inc. received FDA clearance for its Abdo-Triage software.
- 2The clearance expands the product to flag up to 17 findings on abdomen-pelvis CT images.
- 3A previous clearance was granted in late 2025.
- 4The startup is based in Boston and was founded in 2024.
- 5The product aims to assist clinical teams by triaging a broader range of findings on CT scans.
Why It Matters
This FDA clearance reflects growing regulatory confidence in AI solutions for radiology, offering broader triage of critical findings for abdomen-pelvis CT. It underlines AI’s potential to streamline radiologist workflow and prioritize urgent cases in clinical practice.
Source
Radiology Business
Related News
•Radiology Business
RadNet's DeepHealth Receives FDA Clearance for Chest X-ray AI Tool
RadNet's DeepHealth receives FDA 510(k) clearance for AI-powered chest X-ray abnormality detection.
•Radiology Business
Real-World Study: Radiology AI Best in Emergency and Inpatient Settings
A commercial AI tool for intracranial aneurysm detection outperformed in inpatient and emergency settings but yielded limited benefits for outpatients in a major health system study.
•Radiology Business
Epsilon Health Launches With $28M to Build 'AI-Native' Imaging Practice
Epsilon Health has exited stealth mode, raising nearly $28M to launch an 'AI-native' radiology imaging group aimed at addressing the U.S. radiologist shortage.